The Hyperhidrosis Treatment market size is USD 734.5 Mn in 2026.
The Hyperhidrosis Treatment market is projected to grow at a CAGR of 6% by 2033.
The Hyperhidrosis Treatment market growth drivers include rising secondary hyperhidrosis cases, increasing adoption of botulinum toxin therapies, and growing R&D activities.
North America is the dominating region for Hyperhidrosis Treatment market.
AbbVie Inc./Allergan, Brickell Biotech, Dermira Inc./Eli Lilly and Company, GlaxoSmithKline plc, and Teva Pharmaceutical Industries Ltd. are some leading industry players in the Hyperhidrosis Treatment market.